tiprankstipranks
Firebrick Pharma Limited (AU:FRE)
ASX:FRE
Australian Market
Want to see AU:FRE full AI Analyst Report?

Firebrick Pharma Limited (FRE) Price & Analysis

8 Followers

FRE Stock Chart & Stats

AU$0.05
AU$0.00(0.00%)
At close: 4:00 PM EST
AU$0.05
AU$0.00(0.00%)

Bulls Say, Bears Say

Bulls Say
Zero Net Debt / Low LeverageA zero-debt balance sheet is a durable financial strength: it reduces solvency risk and preserves capacity to raise debt only if needed. For a cash-burning developer, low leverage provides strategic flexibility to time financing or partnerships without immediate refinancing pressure.
Positive Product-level Gross MarginA ~36% gross margin shows the company can generate positive unit economics when sales occur. This suggests pricing and cost structure at the product level can support future profitability if revenues scale, making margin recovery a realistic path as commercialization progress resumes.
Lean Operating FootprintA very small headcount implies a low fixed-cost base and operational agility. For a developing pharmaceutical business, a lean structure can extend runway, focus R&D spend, and make partnerships or outsourcing more effective as the firm advances products toward commercialization.
Bears Say
Sharp Revenue CollapseA ~74% year-over-year revenue decline is a durable red flag: it undermines the revenue base required to leverage fixed costs, threatens commercial momentum, and increases reliance on external financing or partnerships to support ongoing development and market activities.
Persistent Negative Operating And Free Cash FlowConsistent negative operating and free cash flow indicates the business is not self-funding. Even with improvement versus earlier years, ongoing cash burn forces repeated financing or asset sales, constrains investment in trials or commercialization, and is a sustained solvency risk.
Large Losses And Deeply Negative Returns On EquityVery large operating losses and severely negative ROE reflect unprofitable core operations and erosion of shareholder equity. Over months, this impairs the firm's ability to invest in growth internally, increases dilution risk from future raises, and weakens long-term financial resilience.

Firebrick Pharma Limited News

FRE FAQ

What was Firebrick Pharma Limited’s price range in the past 12 months?
Firebrick Pharma Limited lowest share price was AU$0.04 and its highest was AU$0.09 in the past 12 months.
    What is Firebrick Pharma Limited’s market cap?
    Firebrick Pharma Limited’s market cap is AU$11.12M.
      When is Firebrick Pharma Limited’s upcoming earnings report date?
      Firebrick Pharma Limited’s upcoming earnings report date is Aug 28, 2026 which is in 76 days.
        How were Firebrick Pharma Limited’s earnings last quarter?
        Firebrick Pharma Limited released its earnings results on Mar 04, 2026. The company reported -AU$0.005 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.005.
          Is Firebrick Pharma Limited overvalued?
          According to Wall Street analysts Firebrick Pharma Limited’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does Firebrick Pharma Limited pay dividends?
            Firebrick Pharma Limited does not currently pay dividends.
            What is Firebrick Pharma Limited’s EPS estimate?
            Firebrick Pharma Limited’s EPS estimate for its next earnings report is not yet available.
            How many shares outstanding does Firebrick Pharma Limited have?
            Firebrick Pharma Limited has 285,198,970 shares outstanding.
              What happened to Firebrick Pharma Limited’s price movement after its last earnings report?
              Firebrick Pharma Limited reported an EPS of -AU$0.005 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.407%.
                Which hedge fund is a major shareholder of Firebrick Pharma Limited?
                Currently, no hedge funds are holding shares in AU:FRE
                What is the TipRanks Smart Score and how is it calculated?
                Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

                  Company Description

                  Firebrick Pharma Limited

                  Firebrick Pharma Limited, an enterprise established in 2012 and headquartered in Melbourne, Australia, is dedicated to the research, development, and market launch of Nasodine, a nasal spray treatment for the common cold, exclusively for the Australian market.

                  Firebrick Pharma Limited (FRE) Earnings & Revenues

                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  Hexima Ltd
                  Botanix Pharmaceuticals Limited
                  Recce Pharmaceuticals Ltd.
                  Arovella Therapeutics Limited
                  Inoviq Ltd

                  Options Prices

                  Currently, No data available
                  ---
                  Popular Stocks